TNL Mediagene has regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement, following a decision by the Nasdaq Hearings Panel dated August 23, 2026. The Tokyo-based technology company announced the development on October 16, 2026, after receiving a confirmation letter from The Nasdaq Stock Market LLC on October 14, 2026.
While the bid price issue is resolved, the company's continued listing on The Nasdaq Capital Market remains conditional. Under the terms of the Hearings Panel's decision, TNL Mediagene must show that it meets the $2.5 million stockholders' equity minimum set by Nasdaq Listing Rule 5550(b)(1) by October 30, 2026. The company noted that there is no assurance it will meet this specific financial threshold within the required timeframe.
During this exception period, TNL Mediagene ordinary shares will continue to trade on The Nasdaq Capital Market under the ticker symbol TNMG. The company, which operates multi-language digital media brands across Asia, was formed in May 2023 through the merger of Japan's Mediagene Inc. and Taiwan's The News Lens Co., Ltd.
TNL Mediagene provides AI-driven advertising, marketing technology, content commerce, and data analytics solutions to brands and agencies. Its technology platforms are supported by a portfolio of digital media brands operating in Japanese, Chinese, and English. These brands cover business, technology, lifestyle, and culture sectors, providing audience engagement and first-party data for the company's integrated digital solutions. The company employs approximately 480 people with offices located in Japan and Taiwan.
The announcement includes standard cautionary statements regarding forward-looking statements as defined by Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The company identifies risks related to its ability to demonstrate compliance with stockholders' equity and other continued listing requirements, including the potential delisting of its securities from Nasdaq. TNL Mediagene states that actual results may differ materially from those expressed in these forward-looking statements due to various uncertainties described in its filings with the U.S. Securities and Exchange Commission.